# VERA THERAPEUTICS INC (VERA)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/VERA/

- Reporting holders: 6
- Reported value: $2.5M
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [EASTERN BANK](https://holderbook.com/funds/1126395-eastern-bank/) | $1.8M | 56,050 | 0.0% | 9 |
| [MFA WEALTH ADVISORS, LLC](https://holderbook.com/funds/1688184-mfa-wealth-advisors-llc/) | $631.2K | 19,547 | 0.1% | 1 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $29.3K | 908 | 0.0% | 12 |
| [GK Wealth Management LLC](https://holderbook.com/funds/2069222-gk-wealth-management-llc/) | $14.5K | 450 | 0.0% | 1 |
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $775 | 24 | 0.0% | 5 |
| [Versant Capital Management, Inc](https://holderbook.com/funds/1735057-versant-capital-management-inc/) | $678 | 21 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 6 | $2.5M |
| Q2 2026 | 224 | $3.6B |
| Q1 2026 | 229 | $3.0B |
| Q4 2025 | 219 | $3.8B |
| Q3 2025 | 176 | $1.9B |
| Q2 2025 | 175 | $1.6B |
| Q1 2025 | 180 | $1.6B |
| Q4 2024 | 178 | $2.7B |
| Q3 2024 | 174 | $2.4B |
| Q2 2024 | 170 | $2.0B |
| Q1 2024 | 158 | $2.4B |
| Q4 2023 | 96 | $658.0M |